Bispecific Antibody Market 2023 to 2033: Advanced R&D Process Strategies
The global bispecific antibody market is expected to reach $500 million by the end of 2023, and $1 billion by 2033, representing a 7.2% CAGR. The bispecific antibody business has benefited greatly from antibody engineering. Much progress has been achieved in generating innovative antibody formats and engineering procedures that allow the creation of bispecific antibodies with improved efficacy and stability in recent years. Advances in recombinant DNA technology and protein engineering, for example, have permitted the development of bispecific antibodies with enhanced pharmacokinetics, lower immunogenicity, and higher tumour penetration. The rising prevalence of cancer and autoimmune illnesses is also driving the bispecific antibody market. These disorders continue to be a large unmet medical need, and developing novel and effective therapeutics is critical for improving patient outcomes. Bispecific antibodies show promise in the treatment of cancer and autoimmune illnesses becaus...